Zachariah Serber, Chief Science Officer at Zymergen Inc. (ZY), sold 9,446 shares at $3.91 ($37K) on 2022-02-25, disclosed to the SEC on 2022-03-01.
Scheduled sale ($37k) by Chief Science Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.91 | 4,011 | $16K | 42.3% |
| 2 | $3.93 | 5,435 | $21K | 57.7% |
| Total | $3.92 avg | 9,446 | $37K | 100% |
| Filing → |
| ZY | SELL | 2022-08-04 | $8K | — | Filing → |
| ZY | SELL | 2022-07-07 | $4K | — | Filing → |
| ZY | SELL | 2022-06-06 | $5K | — | Filing → |